Annals of Hematology

, Volume 96, Issue 11, pp 1915–1920 | Cite as

Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients

  • Hiroyuki TsudaEmail author
  • Takahiro Tsuji
  • Mayumi Tsuji
  • Hiroshi Yamasaki
Original Article


Bleeding is the most important clinical outcome in patients with immune thrombocytopenia (ITP), and the goal of therapy in such cases is to treat or prevent bleeding. The frequency of and risk factors for bleeding events in ITP have only recently been identified in several large-scale studies. However, there is little published information about severe life-threatening bleeding in ITP. To clarify the clinical features of life-threatening bleeding in patients with primary ITP, we systematically reviewed the medical records of all ITP patients that were admitted to our hospital between January 1, 1992, and December 31, 2015. Of 169 consecutive inpatients with primary ITP, 8 suffered life-threatening bleeding (10 episodes: gastrointestinal, 4 cases; pulmonary, 1 case; and intracranial, 5 cases). All of these patients were ≥ 60 years of age and had platelet counts of < 20 × 109/L. The highest incidence of such bleeding was found among elderly patients in their 80s with platelet counts of < 5 × 109/L. Among the patients aged ≥ 60 years with platelet counts of < 20 × 109/L, the background data of the patients with and without life-threatening bleeding episodes were compared. It was shown that the patients in the bleeding group were older than those in the non-bleeding group (80.13 ± 2.31 vs. 73.39 ± 2.51 years, p = 0.0266). Hypertension, diabetes mellitus, anticoagulant use, ITP phase, and sex were not identified as strong risk factors for life-threatening bleeding. Combining age and the platelet count might be a useful way of identifying ITP patients that are at risk of life-threatening bleeding. Most intracranial hemorrhaging (4/5) was spontaneous and multifocal, suggesting that these might be characteristics of ITP-related bleeding in elderly patients.


Hemorrhaging ICH Primary ITP Thrombocytopenia 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Diz-Kucukkaya R, Lopez JA (2016) Thrombocytopenia. In: Kaushansky K, Lichtman PJT et al (eds) Williams Hematology, 9th edn. McGraw Hill, New York, pp 1993–2024Google Scholar
  2. 2.
    Portielje JEA, Westendorp RGJ, Kluin-Nelemans HC, Brand A (2001) Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 97:2549–2554CrossRefPubMedGoogle Scholar
  3. 3.
    Frederiksen H, Maegbaek ML, Norgaard M (2014) Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study. Br J Haematol 166:260–267CrossRefPubMedGoogle Scholar
  4. 4.
    Lacey JV, Penner JA (1977) Management of idiopathic thrombocytopenic purpura in adult. Sem Thromb Hemos 3:160–174CrossRefGoogle Scholar
  5. 5.
    Nahirniak S, Slichter SJ, Tanael S et al (2015) Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia. Transfus Med Rev 29:3–13CrossRefPubMedGoogle Scholar
  6. 6.
    Schattner E, Bussel J (1994) Mortality in immune thrombocytopenic purpura: report of seven cases and consideration of prognostic indicators. Am J Hematol 46:120–126CrossRefPubMedGoogle Scholar
  7. 7.
    Neunert C, Noroozi N, Norman G et al (2015) Severe bleeding events in adults and children with primary immune thrombocythemia: a systemic review. J Thromb Hemos 12:457–464CrossRefGoogle Scholar
  8. 8.
    Cohen YC, Djulbegovic B, Lubovitz MB (2000) The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 160:1630–1638CrossRefPubMedGoogle Scholar
  9. 9.
    Kuhne T, Berchtold W, Michaels LA et al (2011) Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group. Haematologica 96:1831–1837CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Neunert CE, Buchanan GR, Imbach P et al (2008) Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood 112:4003–4008CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Neylon AJ, Saunder PWG, Howard MR et al (2003) Clinical significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients. Br J Haematol 122:966–974CrossRefPubMedGoogle Scholar
  12. 12.
    Moulis G, Palmaro A, Montastruc JL et al (2014) Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood 124:3308–3315CrossRefPubMedGoogle Scholar
  13. 13.
    Altomare I, Cetin K, Wetten S, Wasser JS (2016) Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claim database in the US. Clin Epidemiol 8:231–239PubMedPubMedCentralGoogle Scholar
  14. 14.
    Arnold DM (2015) Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2015:237–242PubMedGoogle Scholar
  15. 15.
    Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 111:2386–2393CrossRefGoogle Scholar
  16. 16.
    Rodeghiero F, Michel M, Gernsheimer T et al (2013) Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 121:2596–2606CrossRefPubMedGoogle Scholar
  17. 17.
    Frederiksen H, Schmidt K (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 94:909–913PubMedGoogle Scholar
  18. 18.
    Mahevas M, Michel M, Godeau B (2016) How we manage immune thrombocytopenia in elderly. Br J Haematol 173:844–856CrossRefPubMedGoogle Scholar
  19. 19.
    Cortelazzo S, Finazzi G, Buelli M et al (1991) High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 77:31–33PubMedGoogle Scholar
  20. 20.
    Michel M, Rauzy OB, Thoraval FR et al (2011) Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study. Am J Hematol 86:980–984CrossRefPubMedGoogle Scholar
  21. 21.
    Donato AJ, Morgan RG, Walker AE, Lesniewski LA (2015) Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol 89(Pt B):122–135CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Hanson SR, Slichter SJ (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 66:1105–1109PubMedGoogle Scholar
  23. 23.
    Psaila B, Petrovic A, Page LK et al (2009) Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 114:4777–4783CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Department of Hematology and OncologyKumamoto City HospitalKumamotoJapan
  2. 2.Department of Environmental HealthUniversity of Occupational and Environmental HealthKitakyushuJapan

Personalised recommendations